Skip to content
Open access

Glycemic Variability and Its Outcome in Intensive Care Unit Patients with Sepsis in a Tertiary Care Centre, Puducherry

Oct 2026 · International Journal of Drug Delivery Technology · 0 citations · 11 references

Abstract

Background : Sepsis-induced metabolic dysregulation produces pronounced fluctuations in blood glucose that persist even in the absence of chronic diabetes. While absolute hyperglycaemia has historically guided glycaemic management in intensive care, emerging evidence suggests that glycemic variability (GV)—the degree of oscillation in blood glucose over time—may independently predict adverse outcomes in critically ill patients. Data from Indian tertiary care settings remain limited. Objective : To evaluate glycemic variability using the coefficient of variation (CV) of blood glucose and to determine its association with ICU mortality, length of ICU stay (LOS), organ support requirements, and final hospital outcome in sepsis patients admitted to a tertiary care ICU in Puducherry. Methods : Prospective observational single-centre cohort study, seventy-two ICU patients fulfilling at least two sepsis criteria (Surviving Sepsis Campaign Guidelines 2026) were enrolled between April and June 2026. Capillary or venous blood glucose was recorded every 6 hours for the first 72 hours of ICU admission. Glycemic variability was quantified as CV (%) = (SD / Mean BG) × 100. Patients were stratified as High GV (CV ≥ 36%) or Low GV (CV < 36%). Clinical outcomes were recorded at ICU or hospital discharge. Statistical analysis employed independent samples t-test, chi-square test, Fisher's exact test, and Pearson correlation using SPSS v23.0. Results : Of 72 patients (mean age 54.4 ± 15.1 years; 56.9% male; 58.3% diabetic), 26 (36.1%) had High GV and 46 (63.9%) had Low GV. ICU mortality was significantly higher in the High GV group (42.3% vs 4.3%; p < 0.001). Mean ICU LOS was prolonged in High GV patients (13.0 ± 4.2 vs 9.6 ± 3.4 days; p = 0.001). Multiple organ dysfunction syndrome (MODS) occurred significantly more in the High GV group (57.7% vs 30.4%; p = 0.023). A significant positive correlation was demonstrated between CV and ICU LOS (Pearson r = 0.42, p < 0.001). APACHE II and SOFA Day 1 scores were significantly higher in the High GV group (p < 0.05). All nine episodes of hypoglycaemia occurred exclusively within the High GV group. Conclusion : High glycemic variability (CV ≥ 36%), as measured from routine bedside glucose monitoring, is a clinically significant and statistically robust predictor of ICU mortality, prolonged stay, and greater illness severity in patients with sepsis. Integration of GV metrics into routine ICU glycaemic assessment protocols may enhance risk stratification and guide targeted glucose management strategies in resource-limited settings.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.